TSE:NVCN Neovasc (NVCN) Stock Price, News & Analysis → Biden Nomination CANCELED? (From The Freeport Society) (Ad) Free NVCN Stock Alerts C$40.15 +0.23 (+0.58%) (As of 04/10/2023) Add Compare Share Share Today's RangeC$39.89▼C$40.1550-Day RangeC$40.15▼C$40.1552-Week RangeC$6.00▼C$41.20Volume399 shsAverage Volume2,123 shsMarket CapitalizationC$110.81 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Ad True Market Insiders4 Cryptos BETTER than BitcoinFormer Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than BitcoinClick For My #1 FREE Crypto for 2024 About Neovasc Stock (TSE:NVCN)Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.Read More NVCN Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NVCN Stock News HeadlinesMay 14, 2024 | americanbankingnews.comNeovasc (TSE:NVCN) Stock Price Up 0.6%February 14, 2024 | investing.comAptose Biosciences Inc (APS)April 6, 2023 | theglobeandmail.comClosing Bell: Neovasc Inc up on Thursday (NVCN)February 1, 2023 | theglobeandmail.comNeovasc: Top 25 Performing Stocks Year-to-Date on Toronto Stock Exchange (NVCN)January 17, 2023 | finance.yahoo.comShockwave Medical to Acquire NeovascJanuary 17, 2023 | marketwatch.comShockwave Medical to Buy Neovasc for $75 MillionJanuary 17, 2023 | benzinga.comSHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Neovasc Inc. (NVCN)November 11, 2022 | seekingalpha.comNeovasc Inc. (NVCN) Q3 2022 Earnings Call TranscriptNovember 8, 2022 | finance.yahoo.comNeovasc Reducer Obtains U.S. Outpatient ReimbursementOctober 30, 2022 | finance.yahoo.comNeovasc Inc. (NVCN)September 20, 2022 | finance.yahoo.comNeovasc Provides Corporate Update Following Clinical Data ReleaseSeptember 16, 2022 | finance.yahoo.comNeovasc to Participate in LSI Europe 2022 Emerging MedTech SummitSeptember 15, 2022 | reuters.comNVCN.TO - Neovasc Inc | Stock Price & Latest News | ReutersAugust 30, 2022 | finance.yahoo.comNeovasc to Participate in H.C. Wainwright 24th Annual Global Investment ConferenceAugust 11, 2022 | seekingalpha.comNeovasc Inc. (NVCN) CEO Fred Colen on Q2 2022 Results - Earnings Call TranscriptJuly 28, 2022 | finance.yahoo.comNeovasc to Report Second Quarter Financial Results on August 11, 2022July 26, 2022 | marketwatch.comNeovasc Says FDA Approves Protocol Supplement for Angina StudyJuly 26, 2022 | finance.yahoo.comNeovasc Announces FDA Approval of Planned COSIRA II Sub-studies and Single Arm Registry to Allow Inclusion of Additional Specified Patient PopulationsJuly 5, 2022 | ca.finance.yahoo.comStocks in play: Neovasc IncJune 8, 2022 | finance.yahoo.comNeovasc to Participate in Sidoti & Co. Summer Small Cap Virtual Investor ConferenceMay 23, 2022 | finance.yahoo.comNeovasc to Participate in H.C. Wainwright Global Investment ConferenceMay 13, 2022 | apnews.comNeovasc Announces First Quarter Financial Results and Provides Corporate UpdateMay 13, 2022 | seekingalpha.comNeovasc Inc. (NVCN) CEO Fred Colen on Q1 2022 Results - Earnings Call TranscriptMay 11, 2022 | seekingalpha.comNeovasc Q1 Earnings PreviewApril 29, 2022 | finance.yahoo.comNeovasc to Report First Quarter Financial Results on May 12, 2022See More Headlines Industry, Sector and Symbol Stock ExchangeTSE SectorManufacturing Industry Surgical & Medical Instrument Manufacturing Sub-IndustryN/A Current SymbolTSE:NVCN CUSIPN/A CIKN/A Webwww.neovasc.com Phone16042704344FaxN/AEmployees49Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($20.44) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-33,520,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-78.25% Return on Assets-32.95% Debt Debt-to-Equity Ratio44.86 Current Ratio8.44 Quick Ratio8.04 Sales & Book Value Annual SalesC$3.11 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow1.05 Book ValueC$10.22 per share Price / BookN/AMiscellaneous Outstanding Shares2,760,000Free FloatN/AMarket CapC$110.81 million OptionableNot Optionable Beta2.01 Key ExecutivesMr. Fredericus A. Colen (Age 71)Pres, CEO & Director Comp: $2.59MMr. Christopher Clark B.A. (Age 51)BA (Honours), C.A., CA, PgD, CFO & Corp. Sec. Comp: $1.42MMr. William Reed Little (Age 52)Chief Operating Officer Comp: $1.2MMr. John Christopher Panton (Age 56)Chief Quality Officer Comp: $505.88kSarah Marie-Hodgson GallagherVP of Clinical AffairsKey CompetitorsRMP EnergyTSE:RMPBrightPath Early LearningCVE:BPE298835 (GBU.TO)TSE:GBUWesternZagros Resources ULC,CVE:WZR812575 (SGF.TO)TSE:SGFView All Competitors NVCN Stock Analysis - Frequently Asked Questions How do I buy shares of Neovasc? Shares of NVCN stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (TSE:NVCN) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaElon’s New Device is About to Shock the WorldInvestorPlaceBiden Nomination CANCELED?The Freeport SocietyShocking: One AI startup's revenue could surge 4,735%Manward PressUrgent Nvidia WarningAltimetry"The Biggest Drug Ever" Is ComingBehind the MarketsProtect Your Bank Account Before It’s Too LateWeiss RatingsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist My Default Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.